BRIEF-Lippo China Resources says offeror and subscriber entered into an agreement
* Subscriber agreed to sell and offeror agreed to purchase s$15 million in principal amount of T2 CN B
March 3 Immunomedics Inc:
* Continue to pursue legally justified relief against venBio Select Advisor LLC and venBio's four director candidates in court
* Immunomedics intends to proceed with its annual meeting scheduled for Friday
* Intends to seek expedited discovery, expedited trial with respect to "questionable actions" actions employed by venBio
* Says will promptly seek appropriate relief in a proceeding in Delaware chancery court Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)
SINGAPORE, April 21 Top shareholders in Singapore telecoms company M1 Ltd have approached potential buyers China Mobile and global private equity firms, among others, to sell their combined majority stake in the firm, sources familiar with the matter said.